BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 13876510)

  • 1. The stathmokinetic effect of vincaleukoblastine on normal bone marrow and leukemic cells.
    CARDINALI G; CARDINALI G; BLAIR J
    Cancer Res; 1961 Dec; 21():1542-4. PubMed ID: 13876510
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of colchicine and vincaleukoblastine on bone marrow mitotic activity in Syrian hamster.
    CARDINALI G; CARDINALI G; HANDLER AH; AGRIFOGLIO MF
    Proc Soc Exp Biol Med; 1961; 107():891-2. PubMed ID: 13876511
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of vincaleukoblastine on primary cultures of human neoplasms. A preliminary report.
    WALKER DG; WRIGHT JC
    Cancer Chemother Rep; 1961 Oct; 14():139-44. PubMed ID: 14004574
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitumor principles derived from Vinca rosea Linn. I. Vincaleukoblastine and leurosine.
    JOHNSON IS; WRIGHT HF; SVOBODA GH; VLANTIS J
    Cancer Res; 1960 Aug; 20():1016-22. PubMed ID: 14407465
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological properties of Vincaleukoblastine, an alkaloid in Vinca rosea Linn, with reference to its antitumor action.
    CUTTS JH; BEER CT; NOBLE RL
    Cancer Res; 1960 Aug; 20():1023-31. PubMed ID: 13719013
    [No Abstract]   [Full Text] [Related]  

  • 6. Vincaleukoblastine. I. Preliminary clinical studies.
    HODES ME; ROHN RJ; BOND WH
    Cancer Res; 1960 Aug; 20():1041-9. PubMed ID: 14402218
    [No Abstract]   [Full Text] [Related]  

  • 7. [Grafts of bone marrow after total irradiation of leukemic mice followed by the administration of an antimitotic product].
    MATHE G; AMIEL JL; NIEMETZ JL
    Bull World Health Organ; 1962; 26(5):692-5. PubMed ID: 14471073
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bone marrow grafts after total irradiation of leukemic mice followed by administration of an antimitotic agent to reduce the incidence of a secondary syndrome and to enhance the antileukemic effect].
    MATHE G; AMIEL JL; NIEMETZ J
    C R Hebd Seances Acad Sci; 1962 May; 254():3603-5. PubMed ID: 14471072
    [No Abstract]   [Full Text] [Related]  

  • 9. [Research on the comparative action of cyclophosphamide (Endoxan) and x-irradiation on bone marrow cells in the rat].
    CHEVALLIER A; MANUEL S; CHATEAU D
    C R Seances Soc Biol Fil; 1962; 156():372-5. PubMed ID: 13878821
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of the cytostatic endoxan and trisethyleniminobenzoquinone on the bone marrow and peripheral blood of the rat].
    BIERBRAUER U
    Folia Haematol (Frankf); 1961 Aug; 5():143-61. PubMed ID: 13869053
    [No Abstract]   [Full Text] [Related]  

  • 11. THE CYTOSTATIC ACTION OF VINCALEUKOBLASTINE.
    HAMPEL KE; GERHARTZ H
    Acta Unio Int Contra Cancrum; 1964; 20():214-7. PubMed ID: 14151889
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of simultaneously incurred damage to bone marrow and tumor tissue of animals treated with anticancer agents.
    VOGEL AW
    Cancer Res; 1961 Jun; 21():636-41. PubMed ID: 13781791
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative studies on the effect of N,N',N''-triethylenethiophosphoramide (thio-TEPA) on human blood and bone marrow cells and on fibroblasts in vitro].
    ALBRECHT M; KRETSCHMER V
    Folia Haematol (Frankf); 1961 Aug; 5():272-80. PubMed ID: 13860164
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative testing of cytostatics on the peripheral blood and bone marrow of the rat].
    GERHARTZ H
    Blut; 1959 Dec; 5():360-6. PubMed ID: 13827483
    [No Abstract]   [Full Text] [Related]  

  • 15. A COMPARISON OF CYTOLOGIC EFFECTS OF LEUROSINE METHIODIDE AND VINBLASTINE IN THE TISSUE CULTURE.
    PALMER CG; WARREN AK; SIMPSON PJ
    Cancer Chemother Rep; 1963 Sep; 31():1-2. PubMed ID: 14066228
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bone marrow in vitro under the influence of cytostatic and hormonal substances. An experiment with a planimetric test method].
    THOMAS K; SEIDLER E
    Folia Haematol (Frankf); 1960 Mar; 4():121-39. PubMed ID: 13856412
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects on the marrow of chemotherapy, used for the treatment of lymphomas and leukaemias.
    MADIGAN J; MOTTERAM R
    Acta Unio Int Contra Cancrum; 1959; 15(Suppl 1)():194-5. PubMed ID: 14419682
    [No Abstract]   [Full Text] [Related]  

  • 18. Vincaleukoblastine. IV. A summary of two and one-half years' experience in the use of vinblastine.
    HODES ME; ROHNRJ ; BOND WH; YARDLEY JM; CORPENING WS
    Cancer Chemother Rep; 1962 Feb; 16():401-6. PubMed ID: 13907938
    [No Abstract]   [Full Text] [Related]  

  • 19. [VINCALEUKOBLASTINE, AN ALKALOID WITH ANTIBLASTIC ACTIVITY].
    MASCITELLI-CORIANDOLI E
    Boll Chim Farm; 1963 Nov; 102():745-50. PubMed ID: 14109586
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of the specificity of anti-proliferative drugs. Comparison of nitrogen mustard, triethylene melamine and cyclophosphamide].
    SCALTRINI GC; TOGNELLA S; CONIGLIARO S; GRIFONI V
    Haematol Lat; 1961; 4():411-22. PubMed ID: 14497771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.